Showing 2,721 - 2,740 results of 17,986 for search 'significantly ((((teer decrease) OR (((we decrease) OR (nn decrease))))) OR (a decrease))', query time: 0.72s Refine Results
  1. 2721

    Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

    Published 2025
    “…</p><p>Conclusions</p><p>Liver cancer morbidity and mortality rates have risen in Kazakhstan over the past decade, with a slight decrease during the early COVID-19 pandemic. …”
  2. 2722
  3. 2723
  4. 2724
  5. 2725

    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”
  6. 2726

    Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”
  7. 2727

    Image 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”
  8. 2728
  9. 2729
  10. 2730
  11. 2731

    Demographic data. by Narisa Rattanalert (21445983)

    Published 2025
    “…Rubric scores for performing the LIO-ROP on a schematic eye significantly improved across all steps of the procedure between pre- and post-LIO-ROP practice. …”
  12. 2732

    Neuroprotective effects of Cannabidiol in 5XFAD Mice: Reducing amyloid and tau burden in the dorsal subiculum by Muhammad Kamal Hossain (19814445)

    Published 2024
    “…Interpretation:</b> Our results showed that CBD treatment led to a significant reduction in Aβ accumulation and a marked decrease in hyperphosphorylated tau in treated mice compared to controls. …”
  13. 2733
  14. 2734
  15. 2735

    Raw data. by Camilla Albano (16446679)

    Published 2025
    “…Conversely, silencing FASN or applying FASN inhibitors (<i>i.e</i>., CMS121 and C75) markedly reduces the infectivity of newly released HSV-1 virions, suggesting that, while initial replication remains unaffected, FASN is crucial for maintaining virion structure and facilitating entry into host cells. Additionally, we show that a source of lipid-rich external factors provided by fetal bovine serum significantly increases HSV-1 infectivity. …”
  16. 2736

    Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  17. 2737

    Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  18. 2738

    Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  19. 2739
  20. 2740

    Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx by Naama Lax (20998004)

    Published 2025
    “…We evaluated its efficacy and safety in pediatric patients with TMA sub-types: atypical HUS (aHUS), Shiga toxin-producing Escherichia coli (STEC)-HUS, and transplant-associated TMA (TA-TMA).…”